| 1 |
史红阳，邓文静，张玉萍，等. 特发性肺纤维化患者外周血中CD4～＋Foxp3～＋调节性T细胞表达水平分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(6):694-697.
|
| 2 |
熊珊珊. 调节性T淋巴细胞(Treg)在放射性肺纤维化中的作用及机制研究[D]. 中国人民解放军军事医学科学院，2015: 23-46.
|
| 3 |
Meduri GU, Eltorky MA. Understanding ARDS-associated fibroproliferation [J]. Intensive Care Med, 2015, 41(3):517-520.
|
| 4 |
Hendrickson CM, Crestani B, Matthay MA. Biology and pathology of fibroproliferation following the acute respiratory distress syndrome[J]. Intensive Care Med, 2015, 41(1):147-150.
|
| 5 |
Moore MW, Herzog EL. Regulatory T Cells in Idiopathic Pulmonary Fibrosis[J]. Am J Pathol, 2016, 186(8):1978-1981.
|
| 6 |
Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4＋CD25＋ regulatory T cells[J]. Nat Immunol, 2003, 4(4):330-336.
|
| 7 |
Lo Re S, Lecocq M, Uwambayinema F, et al. Platelet-derived growth factor-producing CD4＋ Foxp3＋ regulatory T lymphocytes promote lung fibrosis[J]. Am J Respir Crit Care Med, 2011, 184(11):1270-1281.
|
| 8 |
Peng X, Moore MW, Peng H, et al. CD4＋CD25＋FoxP3＋ Regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-beta1 exposed murine lung[J]. Front Pharmacol, 2014, 5:80.
|
| 9 |
Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation[J]. Mucosal Immunol, 2009, 2(2):103-121.
|
| 10 |
Kotsianidis I, Nakou E, Bouchliou I, et al. Global Impairment of CD4＋CD25＋FOXP3＋Regulatory T Cells in Idiopathic Pulmonary Fibrosis[J]. Am J Respir Crit Care Med, 2009, 179(12):1121-1130.
|
| 11 |
Liu M, Zeng X, Wang J, et al. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis[J]. Stem Cell Res Ther, 2016, 7(1):63.
|
| 12 |
Xiong S, Guo R, Yang Z, et al. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ，IL-12/IL-4, IL-5 balance[J]. Immunobiology, 2015, 220(11):1284-1291.
|
| 13 |
Reilkoff RA, Peng H, Murray LA, et al. Semaphorin 7a＋ Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1-induced Pulmonary Fibrosis[J]. Am J Respir Crit Care Med, 2013, 187(2):180-188.
|
| 14 |
Galati D, De Martino M, Trotta A, et al. Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients[J]. Cytokine, 2014, 66(2):119-126.
|
| 15 |
Chen Y, Li C, Lu Y, et al. IL-10-Producing CD1dhiCD5＋ Regulatory B Cells May Play a Critical Role in Modulating Immune Homeostasis in Silicosis Patients[J]. Front Immunol, 2017, 8:110.
|
| 16 |
Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4＋ T cells expressing the FoxP3 transcription factor[J]. Immunity, 2009, 30(6):899-911.
|
| 17 |
Hou Z, Ye Q, Qiu M, et al. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis[J]. Respiratory Research, 2017, 18(1):170.
|
| 18 |
Das M, Zhu C, Kuchroo VK. Tim-3 and its role in regulating anti-tumor immunity[J]. Immunol Rev, 2017, 276(1):97-111.
|
| 19 |
Gautron AS, Dominguez-Villar M, de Marcken M, et al. Enhanced suppressor function of TIM-3＋ FoxP3＋ regulatory T cells[J]. Eur J Immunol, 2014, 44(9):2703-2711.
|
| 20 |
Song H, Zhou Y, Li G, et al. Regulatory T cells contribute to the recovery of acute lung injury by upregulating Tim-3[J]. Inflammation, 2015, 38(3):1267-1272.
|
| 21 |
Liu X, Jiang S, Zhang Q, et al. Tim-3 Regulates Tregs′Ability to Resolve the Inflammation and Proliferation of Acute Lung Injury by Modulating Macrophages Polarization[J]. Shock, 2018, 50(4):455-464.
|
| 22 |
Birjandi SZ, Palchevskiy V, Xue YY, et al. CD4＋ CD25 hi Foxp3＋ Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis[J]. Am J Pathol, 2016, 186(8):2008-2020.
|
| 23 |
Zhou L, Chong MM, Littman DR. Plasticity of CD4＋ T cell lineage differentiation[J]. Immunity, 2009, 30(5):646-655.
|
| 24 |
Voo KS, Wang YH, Santori FR, et al. Identification of IL-17-producing FOXP3＋ regulatory T cells in humans[J]. Proc Natl Acad Sci U S A, 2009, 106(12):4793-4798.
|
| 25 |
李树民，鲍文华，赵艳景，等. CCR6、Th9细胞、Th17/Treg细胞失衡在大鼠肺纤维化中的表达及意义[J]. 中国实验诊断学，2018, 22(01):108-112.
|
| 26 |
Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3[J]. Nat Immunol, 2007, 8(3):277-284.
|
| 27 |
Zhou X, Bailey-Bucktrout SL, Jeker LT, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo[J]. Nat Immunol, 2009, 10(9):1000-1007.
|
| 28 |
Bian LQ, Mao L, Bi Y, et al. Loss of regulatory characteristics in CD4＋ CD25＋/hi T cells induced by impaired transforming growth factor beta secretion in pneumoconiosis[J]. APMIS, 2017, 125(12):1108-1116.
|
| 29 |
Basu R, Whitley SK, Bhaumik S, et al. IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance[J]. Nat Immunol, 2015，16(3):286-295.
|
| 30 |
Raijmakers RPH, Sprenkeler EGG, Aleva FE, et al. Toll-like receptor 2 induced cytotoxic T-lymphocyte-associated protein 4 regulates Aspergillus-induced regulatory T-cells with pro-inflammatory characteristics[J]. Sci Rep, 2017, 7(1):11500.
|
| 31 |
Suozzi KC, Stahl M, Ko CJ, et al. Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy[J]. JAAD Case Rep, 2016, 2(3):264-268.
|
| 32 |
Montaudié H, Pradelli J, Passeron T, et al. Pulmonary sarcoid-like granulomatosis induced by nivolumab[J]. Br J Dermatol, 2017, 176(4):1060-1063.
|
| 33 |
Walker LS, Sansom DM. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses[J]. Nat Rev Immunol, 2011, 11(12):852-863.
|
| 34 |
Beriou G, Costantino CM, Ashley CW, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function[J]. Blood, 2009, 113(18):4240-4249.
|
| 35 |
Lee S, Park K, Kim J, et al. Foxp3 expression in induced regulatory T cells is stabilized by C/EBP in inflammatory environments[J]. EMBO Rep, 2018, 19(12): doi: 10.15252/embr.201845995. |
| 36 |
Kotani T, Masutani R, Suzuka T, et al. Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia[J]. Scientific Reports, 2017, 7(1):14608.
|
| 37 |
Zhou X, Su YX, Lao XM, et al. CD19(＋)IL-10(＋) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(＋) T cells to CD4(＋)Foxp3(＋) regulatory T cells[J]. Oral Oncol, 2016, 53:27-35.
|
| 38 |
Flores-Borja F, Bosma A, Ng D, et al. CD19＋CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation[J]. Sci Transl Med, 2013, 5(173):173ra23.
|
| 39 |
Kessel A, Haj T, Peri R, et al. Human CD19(＋)CD25(high) B regulatory cells suppress proliferation of CD4(＋) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells[J]. Autoimmun Rev, 2012, 11(9):670-677.
|
| 40 |
Lu Y, Liu F, Li C, et al. IL-10-Producing B Cells Suppress Effector T Cells Activation and Promote Regulatory T Cells in Crystalline Silica-Induced Inflammatory Response In Vitro[J]. Mediators Inflamm, 2017, 2017:8415094.
|
| 41 |
Khan AR, Hams E, Floudas A, et al. PD-L1hi B cells are critical regulators of humoral immunity[J]. Nat Commun, 2015, 6:5997.
|
| 42 |
Liu Y, Cheng LS, Wu SD, et al. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection[J]. Clin Sci (Lond), 2016, 130(11):907-919.
|
| 43 |
Liu F, Dai W, Li C, et al. Role of IL-10-producing regulatory B cells in modulating T-helper cell immune responses during silica-induced lung inflammation and fibrosis[J]. Sci Rep, 2016, 6(1):28911.
|
| 44 |
Tselios K, Sarantopoulos A, Gkougkourelas I, et al. The influence of therapy on CD4＋CD25(high)FOXP3＋ regulatory T cells in systemic lupus erythematosus patients: a prospective study[J]. Scand J Rheumatol, 2015, 44(1):29-35.
|
| 45 |
Andrade J, Schwarz M, Collard HR, et al. The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes[J]. Chest, 2015 ,148(4):1034-1042.
|
| 46 |
Kamio K, Azuma A, Matsuda K, et al. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation[J]. Respir Res, 2018, 19(1):71.
|
| 47 |
赵娜，吴洁，宋向荣，等. 骨髓间充质干细胞治疗矽肺小鼠肺纤维化效果[J]. 中国职业医学，2017, 44(6):657-663.
|
| 48 |
Liu D, Kong F, Yuan Y, et al. Decorin-Modified Umbilical Cord Mesenchymal Stem Cells (MSCs) Attenuate Radiation-Induced Lung Injuries via Regulating Inflammation, Fibrotic Factors, and Immune Responses[J]. Int J Radiat Oncol Biol Phys, 2018, 101(4):945-956.
|
| 49 |
Boveda-Ruiz D, D′Alessandro-Gabazza CN, Toda M, et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis[J]. Immunobiology, 2013, 218(2):245-254.
|